Absci Corp. (ABSI)
8.84
-0.71
(-7.43%)
USD |
NASDAQ |
Aug 24, 16:00
8.88
+0.04
(+0.45%)
Pre-Market: 08:39
Absci Shareholders Equity (Quarterly) : 246.13M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 246.13M |
| March 31, 2026 | 171.97M |
| December 31, 2025 | 189.45M |
| September 30, 2025 | 210.34M |
| June 30, 2025 | 173.37M |
| March 31, 2025 | 198.80M |
| December 31, 2024 | 179.13M |
| September 30, 2024 | 201.34M |
| June 30, 2024 | 221.49M |
| March 31, 2024 | 240.11M |
| December 31, 2023 | 176.18M |
| September 30, 2023 | 196.42M |
| Date | Value |
|---|---|
| June 30, 2023 | 215.40M |
| March 31, 2023 | 253.96M |
| December 31, 2022 | 274.41M |
| September 30, 2022 | 292.94M |
| June 30, 2022 | 316.19M |
| March 31, 2022 | 340.50M |
| December 31, 2021 | 366.11M |
| September 30, 2021 | 388.01M |
| June 30, 2021 | 37.12M |
| March 31, 2021 | 62.87M |
| December 31, 2020 | 67.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Prime Medicine, Inc. | 39.81M |
| Tenax Therapeutics, Inc. | 113.59M |
| Exicure, Inc. | 0.977M |
| Recursion Pharmaceuticals, Inc. | 915.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 268.92M |
| Total Liabilities (Quarterly) | 22.79M |
| Debt to Equity Ratio | 0.0156 |
| Current Ratio | 10.63 |
| Net Debt Paydown Yield | 0.05% |